Patent ID: 8501734

Claim:
A method for the treatment and/or amelioration of a haematological cancer, wherein said method comprises the administration of a pharmaceutically active dose of a compound as defined in formula I to a subject in the need of such a treatment and/or amelioration, wherein said compound is to be administered to the subject in need of such a treatment in combination with an Akt inhibitor, and wherein formula I is wherein R 1 is H or —CH 2 —NR 5 —(CH 2 ) m —CH 3 , whereby m is an integer of 0 to 3 and R 5 is H or C 1 -C 4 alkyl; and R 2 , R 3 , R 4 are independently selected from H, C 1 -C 4 alkyl, OH, NH 2 , CN, Cl, Br, I or F, or a pharmaceutically acceptable salt, derivative or prodrug thereof.